Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma

Although probability of event-free survival in pediatric lymphoblastic T-cell lymphoma (T-LBL) is about 75%, survival in relapsed patients is very poor, so the identification of new molecular markers is crucial for treatment optimization. Here, we demonstrated that the over-expression of miR-223 pro...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Pomari, Elena, Lovisa, Federica, Carraro, Elisa, Primerano, Simona, D’Amore, Emanuele S.G., Bonvini, Paolo, Nigro, Luca Lo, Vito, Rita De, Vinti, Luciana, Farruggia, Piero, Pillon, Marta, Basso, Giuseppe, Basso, Katia, Mussolin, Lara
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5746112/
https://ncbi.nlm.nih.gov/pubmed/29296210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22386
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia